Indaptus Therapeutics, Inc.

INDP

NASDAQHealthcareBiotechnology

Open in GoAI

Latest quote

$1.29

Market data unavailable

Aug 21, 3:55 PM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

37/100

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

Fair Value

Momentum

Neutral

Sentiment

Mixed

Risk resilience

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry: Biotechnology
Sector: Healthcare
Headquarters: US

Market position

Volume: 1.14M
Market cap: 146.08M USD

Financials

Financial snapshot

Latest / TTM

Financial health

Altman Z-score: 129.31
Piotroski F-score: 2 of 9

Earnings

Latest fiscal-year EPS: -21.58; FY2025
Latest fiscal-year revenue: 0 USD; FY2025

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

INDP peers

AMGN

Amgen Inc.

$439.33

+1.29%

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

SNY

Sanofi

$45.85

+1.55%

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

Continue in GoAI

Research INDP

research.disclaimer